|
EP3652542A1
|
|
Methods and means for diagnosing and/or treating a fatiguing illness
|
|
WO2019201430A1
|
|
Sustained energy providing and free radical protective composition
|
|
EP2687264A1
|
|
Macrophage Activating Factor for treatment of endometriosis
|
|
EP2561879A1
|
|
Macrophage activating factor for use in the treatment of chronic fatigue syndrome (CFS) and CFS-related diseases and disorders
|
|
GB201019043D0
|
|
Use of 2',5'-oligoadenylate derivative compounds
|
|
AU2010227529A1
|
|
Methods for the detection and treatment of aberrant prion disease
|
|
SI2401400T1
|
|
Methods and compositions for evaluating chronic immune diseases
|
|
WO2010142322A1
|
|
Methods and kits for detecting, diagnosing and monitoring diseases
|
